Osaic Holdings
AKTX

Osaic Holdings’s Akari Therapeutics AKTX Stock Holding History

Osaic Holdings’s Portfolio AKTX Stock Details AKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3
Closed -$122 – 7429
2024
Q4 		$122 Hold
3
– – ﹤0.01% 7227
2024
Q3 		$295 Hold
3
– – ﹤0.01% 7107
2024
Q2 		$270 Buy
+3
New +$221 ﹤0.01% 7123
2021
Q2 		– Hold
0
– – – 6970
2021
Q1 		– Hold
0
– – – 6782
2020
Q4 		– Hold
0
– – – 6373
2020
Q3 		– Sell
-1
Closed -$1.48K – 6183
2020
Q2 		$2K Hold
1
– – ﹤0.01% 5755
2020
Q1 		$2K Buy
+1
New +$1.39K ﹤0.01% 5639

Other funds holding AKTX

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OFW
Omnia Family Wealth Aventura, Florida $373M AUM 25.3% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Accent Capital Management Centerville, Ohio $206M AUM 29.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
CPG
Cornerstone Planning Group Fairfield, New Jersey $794M AUM 22.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings's AKTX Position: Q1 2025 in Review

Osaic Holdings sold out of Akari Therapeutics (AKTX) in Q1 2025, closing a stake of 3 shares — an estimated $122 sold.

Osaic Holdings first reported a position in AKTX in Q1 2020 and held it in 5 quarters. The position peaked at $2K in Q2 2020. 9 funds tracked by Wall St. Rank hold AKTX as of Q1 2025.

  • Osaic Holdings reported no remaining Akari Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 3 Akari Therapeutics shares in Q1 2025, an estimated $122.
  • Osaic Holdings first reported a position in Akari Therapeutics in Q1 2020 and held it in 5 quarters.
  • Osaic Holdings's Akari Therapeutics position peaked at $2K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Akari Therapeutics as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.